Haemonetics Corp signs supply deal with CSL
- Non-exclusive supply agreement with CSL Plasma Inc.
- CSL expects rollout by end of 2027.
- Transition to Haemonetics devices at all U.S. CSL centers.
Every EDGAR filing for HAEMONETICS CORP (HAE), newest first, with AI summaries and stories.
Next: earnings expected ~Nov 5 · 10-Q expected ~Nov 5 (deadline Nov 5)
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Ownership stake disclosure by AQR CAPITAL MANAGEMENT LLC (amended)
AQR CAPITAL MANAGEMENT LLC, filed by
Martin D Madaus, insider filing for HAE
Martin D Madaus, reporting
Farris Maryanne Maunsell, insider filing for HAE
Farris Maryanne Maunsell, reporting
Michelle L Basil, insider filing for HAE
Michelle L Basil, reporting
Ownership stake disclosure by North Peak Capital Management, LLC (amended)
North Peak Capital Management, LLC, filed by
James DArecca, insider filing for HAE
James DArecca, reporting
Ownership stake disclosure by VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC, filed by
Ownership stake disclosure by VANGUARD PORTFOLIO MANAGEMENT LLC
VANGUARD PORTFOLIO MANAGEMENT LLC, filed by
Ownership stake disclosure by VANGUARD GROUP INC (amended)
VANGUARD GROUP INC, filed by
Ownership stake disclosure by North Peak Capital Management, LLC
North Peak Capital Management, LLC, filed by
Ownership stake disclosure by AQR CAPITAL MANAGEMENT LLC
AQR CAPITAL MANAGEMENT LLC, filed by
Mark W Kroll, insider filing for HAE
Mark W Kroll, reporting
Roy Galvin, insider filing for HAE
Roy Galvin, reporting